37LBA Telotristat etiprate is effective in treating patients with carcinoid syndrome that is inadequately controlled by somatostatin analog therapy (the phase 3 TELESTAR clinical trial)
Michael Kulke, Dieter Hörsch, M. Caplin, Lowell Anthony, Emily K. Bergsland, Kjell Öberg, Staffan Welin, Robert R. Warner, Catherine Lombard‐Bohas, Pamela L. Kunz, Enrique Grande, Juan W. Valle, D Fleming, Pablo Lapuerta, Phillip Banks, Shanna Jackson, Darren Wheeler, Brian Zambrowicz, Arthur Sands, Marianne Pavel
Cited by 19
Abstract
Related Papers
No related papers found
Powered by citation graph analysis